Beverly A. Teicher

Follow

Generating author description...

All published works
Action Title Year Authors
+ FIGURE 3 from Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs 2023 Thomas S. Dexheimer
Nathan P. Coussens
Thomas Silvers
John Wright
Joel Morris
James H. Doroshow
Beverly A. Teicher
+ FIGURE 3 from Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs 2023 Thomas S. Dexheimer
Nathan P. Coussens
Thomas Silvers
John Wright
Joel Morris
James H. Doroshow
Beverly A. Teicher
+ Supplementary Figure 5 from Multicellular complex tumor spheroid response to DNA repair inhibitors in combination with DNA-damaging drugs 2023 Thomas S. Dexheimer
Nathan P. Coussens
Thomas Silvers
John Wright
Joel Morris
James H. Doroshow
Beverly A. Teicher
+ Supplementary Figure 3 from Multicellular complex tumor spheroid response to DNA repair inhibitors in combination with DNA-damaging drugs 2023 Thomas S. Dexheimer
Nathan P. Coussens
Thomas Silvers
John Wright
Joel Morris
James H. Doroshow
Beverly A. Teicher
+ Supplementary Figure 5 from Multicellular complex tumor spheroid response to DNA repair inhibitors in combination with DNA-damaging drugs 2023 Thomas S. Dexheimer
Nathan P. Coussens
Thomas Silvers
John Wright
Joel Morris
James H. Doroshow
Beverly A. Teicher
+ Supplementary Figure 3 from Multicellular complex tumor spheroid response to DNA repair inhibitors in combination with DNA-damaging drugs 2023 Thomas S. Dexheimer
Nathan P. Coussens
Thomas Silvers
John Wright
Joel Morris
James H. Doroshow
Beverly A. Teicher
+ PDF Chat The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation 2022 Julie A. Hong
Bhadrasian Vikram
Jeffrey C. Buchsbaum
Jacek Capala
Alicia A. Livinski
Beverly A. Teicher
Pataje G.S. Prasanna
Mansoor M. Ahmed
Ceferino Obcemea
C. Norman Coleman
+ 3D Cell Culture Models 2017 David M. Evans
Beverly A. Teicher
+ Preclinical Models for High-Dose Therapy 1997 Beverly A. Teicher
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Dependence of the radiation response of an in vitro tumor model on cell cycle effects. 1973 Ralph E. Durand
Robert M. Sutherland
1
+ Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours 1989 EK Rofstad
RM Sutherland
1
+ Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid Model 1988 Robert M. Sutherland
1
+ Cell contact as a possible contribution to radiation resistance of some tumours 1972 Robert M. Sutherland
Ralph E. Durand
1
+ Invited review Multicell spheroids as a model for cell kinetic studies 1990 R. E. Durand
1
+ PDF Chat NCI–RTOG Translational Program Strategic Guidelines for the Early-Stage Development of Radiosensitizers 2012 Yaacov Richard Lawrence
Bhadrasain Vikram
James J. Dignam
Arnab Chakravarti
Mitchell Machtay
Boris Freidlin
Naoko Takebe
Walter J. Curran
Søren M. Bentzen
Paul Okunieff
1
+ Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations 2016 Helen B. Stone
Eric J. Bernhard
C. Norman Coleman
James A. Deye
Jacek Capala
James B. Mitchell
J. Martin Brown
1
+ Radiation response of multicell spheroids--an in vitro tumour model. 1976 Sutherland Rm
Durand Re
1
+ Radiation—Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic Collaboration 2016 Naoko Takebe
Mansoor M. Ahmed
Bhadrasain Vikram
Eric J. Bernhard
James A. Zwiebel
C. Norman Coleman
Charles A. Kunos
1
+ Methodologies in the modeling of combined chemo-radiation treatments 2016 Clemens Grassberger
Harald Paganetti
1
+ PDF Chat The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design 2020 Keith T. Flaherty
Robert J. Gray
Alice Chen
Shuli Li
David R. Patton
Stanley R. Hamilton
P. Mickey Williams
Edith P. Mitchell
A. John Iafrate
Jeffrey Sklar
1